Offer - Urjas Oil for just ₹ 1
StayHappi Teneligliptin + Metformin HCl Extended Release Tablet is an allopathic medicine The correct dosage of StayHappi Teneligliptin + Metformin HCl Extended Release Tablet depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
StayHappi Teneligliptin + Metformin HCl Extended Release Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of StayHappi Teneligliptin + Metformin HCl Extended Release Tablet safe for pregnant women?
StayHappi Teneligliptin + Metformin HCl Extended Release Tablet can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking StayHappi Teneligliptin + Metformin HCl Extended Release Tablet right away. Take your doctor's advice before taking it again.
Is the use of StayHappi Teneligliptin + Metformin HCl Extended Release Tablet safe during breastfeeding?
StayHappi Teneligliptin + Metformin HCl Extended Release Tablet may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of StayHappi Teneligliptin + Metformin HCl Extended Release Tablet on the Kidneys?
Information about safety of StayHappi Teneligliptin + Metformin HCl Extended Release Tablet for kidney is not available since scientific research on this topic is yet to be done.
What is the effect of StayHappi Teneligliptin + Metformin HCl Extended Release Tablet on the Liver?
In the absence of any scientific study on the side effects of StayHappi Teneligliptin + Metformin HCl Extended Release Tablet on the liver, information on safety of StayHappi Teneligliptin + Metformin HCl Extended Release Tablet for liver is unavailable.
What is the effect of StayHappi Teneligliptin + Metformin HCl Extended Release Tablet on the Heart?
In the absence of any scientific study on the side effects of StayHappi Teneligliptin + Metformin HCl Extended Release Tablet on the heart, information on safety of StayHappi Teneligliptin + Metformin HCl Extended Release Tablet for the heart is unavailable.
StayHappi Teneligliptin + Metformin HCl Extended Release Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take StayHappi Teneligliptin + Metformin HCl Extended Release Tablet unless your doctor advises you to do so -
Is this StayHappi Teneligliptin + Metformin HCl Extended Release Tablet habit forming or addictive?
StayHappi Teneligliptin + Metformin HCl Extended Release Tablet does not cause addiction.
Interaction between Food and StayHappi Teneligliptin + Metformin HCl Extended Release Tablet
There isn't any research available on the side effects of taking StayHappi Teneligliptin + Metformin HCl Extended Release Tablet with food.
Interaction between Alcohol and StayHappi Teneligliptin + Metformin HCl Extended Release Tablet
It is difficult to say anything about the effect of StayHappi Teneligliptin + Metformin HCl Extended Release Tablet and alcohol. No research has been done on this yet.
StayHappi Teneligliptin + Metformin HCl Extended Release Tablet increases the sensitivity of insulin, young women with PCOS often have elevated insulin levels and are more likely to develop diabetes. It is often prescribed for women with PCOS to help prevent diabetes. A lifestyle that includes healthy nutrition and daily exercise is the most important part of a PCOS treatment plan.
Lactic acidosis associated with StayHappi Teneligliptin + Metformin HCl Extended Release Tablet treatment is a rare but fatal adverse effect. Lactic acidosis appears to result from biguanide interference causing an increase in production and decrease in clearance of lactate leading to higher cellular lactate levels. A decrease in pyruvate carboxylase activity, the rate-limiting enzyme in the formation of glucose from lactate, can also decrease hepatic metabolism of lactate. leading to increasing lactic acidosis. Signs and symptoms of StayHappi Teneligliptin + Metformin HCl Extended Release Tablet induced lactic acidosis are nonspecific and include anorexia, nausea, vomiting, altered level of consciousness, hyperpnoea, abdominal pain, and thirst.
StayHappi Teneligliptin + Metformin HCl Extended Release Tablet is not a known cause of alopecia (hair loss). However, the conditions treated by StayHappi Teneligliptin + Metformin HCl Extended Release Tablet type 2 diabetes and PCOS, often list hair loss as a possible symptom.
Yes, you can take StayHappi Teneligliptin + Metformin HCl Extended Release Tablet with a beta-blocker. People with diabetes tend to develop heart disease or stroke at an earlier age than the general population. One reason for this is that high glucose levels increase your risk of high blood pressure (hypertension). No harmful interactions are seen between them. However, a recent study suggests that beta-blockers can decrease the plasma level of StayHappi Teneligliptin + Metformin HCl Extended Release Tablet and long-term use can increase lactic acid and uric acid in the blood.
Yes, StayHappi Teneligliptin + Metformin HCl Extended Release Tablet can be taken with the statin. There is no serious or harmful interaction have been observed between them. Some studies say that it's possible your blood sugar (blood glucose) level may increase when you take a statin, which may lead to developing type 2 diabetes. The risk is small but important enough that the Food and Drug Administration (FDA) has issued a warning on statin labels regarding blood glucose levels and diabetes.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826